Company Valuation: American Oncology Network, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024
Market Cap 1 - - 56.35 137.1
Change - - - 143.33%
Enterprise Value (EV) - - 125.3 215.2
Change - - - 71.77%
P/E - - -4.32x -5.7x
PBR - - -0.35x -3.31x
PEG - - - 0.2x
Capitalization / Revenue - - 0.04x 0.08x
EV / Revenue - - 0x 0x
EV / EBITDA - - -0x -0x
EV / EBIT - - -0x -0x
EV / FCF - - - -
FCF Yield - - - -
Dividend per Share 2 - - - -
Rate of return - - - -
EPS 2 - - -1.365 -0.8874
Distribution rate - - - -
Net sales 1 943.7 1,150 1,279 1,759
EBITDA 1 6.99 12.28 -4.668 -5.575
EBIT 1 0.911 5.566 -13.12 -16.09
Net income 1 -0.105 2.589 -5.542 -3.973
Net Debt 36.34 91.97 68.94 78.1
Reference price 2 9.75 10.04 5.90 5.06
Nbr of stocks (in thousands) - - 9,550 27,096
Announcement Date 6/1/23 28/4/23 28/3/24 27/3/25
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 720M
16.77x1.98x9.86x0.62% 106B
11.85x0.37x7.81x3.27% 104B
-253.43x17.64x-298.29x-.--% 52.43B
15.72x1.67x10.09x2.25% 32.79B
26.92x2.34x13.28x0.8% 29.5B
24.68x2.73x13.87x1.3% 28.03B
7.88x1.49x6.58x-.--% 22.8B
29.77x5.31x21.77x2.35% 20.12B
29.88x2.82x12.7x1.48% 16.86B
Average -10.00x 4.04x -22.48x 1.34% 41.33B
Weighted average by Cap. -16.95x 3.79x -28.77x 1.48%

Y-o-Y evolution of P/E

Valuation ratios - P/E - American Oncology Network, Inc.

Historical PBR trend

Valuation ratios - PBR - American Oncology Network, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - American Oncology Network, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - American Oncology Network, Inc.

  1. Stock Market
  2. Stocks
  3. AONC Stock
  4. Valuation American Oncology Network, Inc.